HOTH News and Press, Hoth Therapeutics Inc. From 06/27/19

June 27, 2019 Palm Beach, FL – June 27, 2019 –  In today’s medical and financial environments, defending against risks is essential. In the financial world, financial planning can protect against most risks… in the medical world however, it is the ...

NEW YORK , June 27, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chro...

Gainers:  Roan Resources (NYSE: ROAN ) +44% . Arbutus Biopharma Corporation (NASDAQ: ABUS ) +42% . China Internet Nationwide Financial Services (NASDAQ: CIFS ) +28% . DiaMedica Therapeutics (NASDAQ: DMAC ) +27% . B Communications (NASDAQ: BCOM ) +24% . Hebron Technology (NASDAQ: ...

NEW YORK , June 13, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chron...

June 11, 2019 Palm Beach, FL – June 11, 2019 – Recent reports by industry specialists show that the Atopic Dermatitis Drugs Market Size Worth $6.41 Billion By 2022, exhibiting a CAGR of 6.6% during the forecast period. This is an increase from the 2016 market reven...

NEW YORK , June 10, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis-also known as eczema-as well as dermatological and chronic wound disorders,...

Hoth Therapeutics (NASDAQ: HOTH ) has formed a subsidiary, Hoth Therapeutics Australia Pty Ltd, in anticipation to perform clinical trials for atopic dermatitis. More news on: Spherix Incorporated, Hoth Therapeutics, Inc., Healthcare stocks news, Read more ...

NEW YORK , June 6, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis-also known as eczema-as well as dermatological and chronic wound disorders,...

Gainers:  ReWalk Robotics (NASDAQ: RWLK ) +126% . Genocea Biosciences (NASDAQ: GNCA ) +14% . Dean Foods (NYSE: DF ) +13% . RAVE Restaurant Group (NASDAQ: RAVE ) +11% . Medley Management (NYSE: MDLY ) +10% . Neon Therapeutics (NASDAQ: NTGN ) +10% . Allena Pharmaceuticals (NASDAQ:...

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) was in the red last week, dropping from 3,279.52 points on Tuesday (May 28) to 3,167.47 points as of 1:36 p.m. EDT on Friday (May 31). Despite the index’s dip, a number of NASDAQ biotech and pharma stocks still had notable share price...